Welcome to the February 1 edition of This Week on Estimize. We are pleased to be joined by Joe McCann, founder of Slingshot Insights. In this episode, Leigh and Joe discuss the current state of the health care industry, and look at quarterly expectations for upcoming biotech and pharma companies such as Gilead Sciences, Merck, Biogen Idec, Celgene and Pfizer.
To access the Slingshot Insight projects mentioned by Joe on today's podcast, please click below!
- Understanding the impact of Merck's ZEPATIER on the HCV market as it now competes with HARVONI and Viekira Pak
- Making sense of the NASH market and where the leading development compounds from Intercept and GenFit stand
Want to cull similar insights as were highlighted in this podcast? Come trial the Estimize Screener free for 14 days.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
